Growth in the U.S. peripheral vascular device market, which was valued at $2.8 billion in 2009, will be primarily driven by increased detection and treatment of abdominal aortic aneurysms (AAAs) and peripheral arterial disease (PAD).
AAAs are a swelling of the aorta, caused by a weakness in the aortic wall. If left untreated, approximately one-third of AAAs will rupture, causing death in 75% to 90% of patients. Nearly two million people have aortic aneurysms in the U.S., but only 20% of cases are detected. Improved AAA screening will also lead to increased detection of thoracic aortic aneurysms (TAAs).
Read more about this exciting market in the following press release from iData Research: